Sort
30,917 grants matching “tumor microenvironment”
Genetics and Biology of Pancreatic Duct Adenocarcinoma
$1,770,854Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Center for Modeling Tumor Cell Migration Mechanics
$1,768,788David J Odde · University Of Minnesota · U54 · FY2020 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,766,381E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Genetics and Biology of Pancreatic Duct Adenocarcinoma
$1,765,663Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2006 · CA
Mayo Clinic Ovarian Cancer SPORE
$1,762,703Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2021 · CA
Clinical Program in Pediatric Sarcomas
$1,761,615Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$1,761,342Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2017 · CA
Intracellular In vivo Imaging
$1,761,151Peter L. Choyke · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Phenotype Heterogeneity and Dynamics in SCLC
$1,759,455Vito Quaranta · Vanderbilt University · U54 · FY2021 · CA
SPORE in Prostate Cancer
$1,759,336Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2022 · CA
SPORE in Prostate Cancer
$1,758,412Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2023 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,757,745Joe W. Gray · Oregon Health & Science University · U2C · FY2019 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,757,743Jeremy Goecks · Oregon Health & Science University · U2C · FY2020 · CA
Herpesviral Oncogenesis, Latency and Reactivation
$1,757,717Blossom A Damania · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Center for Modeling Tumor Cell Migration Mechanics
$1,756,806David J Odde · University Of Minnesota · U54 · FY2017 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,756,455Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,755,184Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Center for Cancer Systems Therapeutics (CaST)
$1,754,138Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA
Characterization unit
$1,753,368Kun Zhang · Children'S Hosp Of Philadelphia · U2C · FY2021 · CA
Mayo Clinic Ovarian Cancer SPORE
$1,752,990Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2023 · CA
Modulation of Therapeutic Response
$1,752,978James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Integrated EGFR function in cytokine-driven inflammation and cancer
$1,751,310George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · CA
Mayo Clinic Ovarian Cancer SPORE
$1,749,801Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2022 · CA
Plasma Cells in Health and Disease
$1,747,765Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Molecular Profiling of Clinical Specimens
$1,747,656Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA